EMIS Emis Group Plc

By Anthony O. Goriainoff

The U.K.'s Competition and Markets authority said it hasn't found any competition concerns in the UnitedHealth Group and EMIS Group merger so far following an in-depth investigation, clearing the 1.2 billion pounds ($1.52 billion) deal provisionally.

The regulator said Friday that it will now consult on its findings and listen to any further views before it reaches a final decision, adding that it welcomed responses from interested parties until Sept. 1. Its final report is due Oct. 5, it said.

UnitedHealth and EMIS are specialist health care tech and software companies, which provide services to the U.K.'s National Health Service.

In March the CMA said it decided to refer the merger to a next phase investigation after considering that initial undertakings wouldn't achieve a reasonable solution following concerns that it could reduce competition, leading to worse outcomes for the National Health Service and patients and taxpayers.

Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com

(END) Dow Jones Newswires

August 11, 2023 02:37 ET (06:37 GMT)

Emis (LSE:EMIS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Emis (LSE:EMIS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024